NCT06439407

Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014, a Software for Alleviating Symptoms of Trauma and Stress-related Disorders

An Open-label, Randomized, Controlled, Exploratory Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014, a Software for Alleviating Symptoms of Trauma and Stress-related Disorders

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: S-Alpha Therapeutics, Inc. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

Failure to adapt to stress leads to functional impairments in various areas, including social, occupational, educational, and other significant domains, necessitating therapeutic intervention. Interventions through mobile app in the form of software can provide a new alternative for alleviating symptoms caused by psychological trauma by increasing accessibility to early intervention for trauma patients. This study aims to preliminarily assess the safety and feasibility of a psychological traum intervention by developing SAT-014 to help patients with trauma and stress-related disorder continue effective treatment in a stable environment.

Conditions

• Posttraumatic Stress Disorder

Interventions

Type	Name	Description
DEVICE	SAT-014(Software as Medical Device)	SAT-014(Software as Medical Device) + maintain previous treatment

Timeline

• Start date: 2024-01-03
• Primary completion: 2024-06-28
• Completion: 2024-08-30
• First posted: 2024-06-03
• Last updated: 2024-12-20

Locations

1 site across 1 country: South Korea